7Berger RP, Syminton JM. Long-term clinical manifestation of osteoradionecrosis of the mandible[J]. J Oral Maxillofac Surg, 1990,48 ( 1 ) :82-84.
8Epstein JB, Wong FLW, Stevenson-Moore P. Osteoradionecrosis: clinical experience and a proposal for classification[J]. J Oral Maxillofac Surg, 1987,45(2):104-110.
9Reuther T, SchustervT, Mende U, et al. Osteoradioneerosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-a report of a thirty year retrospective review[J]. Int J Oral Maxillofac Surg, 2003,32(4):289- 295.
10Studer G, Gratz KW, Glanzmann C. Osteoradionecrosis of the manbible in patientstreated with different fractionations[J]. Strahlenther Onkol, 2004, 180(4):233-240.
6Leamon C P. Folate-targeted drug therapy for the treatment of canc-er[J].Current Opioion in Investigational Drugs,2008,(12):1277-1286.
7Leamon C P,Reddy J A. Folate-targeted chemotherapy[J].Advanced Drug Delivery Reviews,2004,(08):1127-1141.
8Gabizon A,Tzemach D,Gorin J. Improved therapeutic activi-ty of folate-targeted liposomal doxorubicin in folate receptor-express-ing tumor models[J].Cancer Chemotherapy and Pharmacology,2010,(01):43-52.
9杨超;巨晓洁.磁性靶向药物制剂的研究进展[A].
10Nakagawa T,Uyama R,Ohashi E,et al.The expression of sia- lyl Lewis X in canine and feline mammary gland tumors[J].Jf Vet Med Sci/Jap Soc Vet Sci?2002,64(10):949-952.
